사이클로헥사실록세인
CYCLOHEXASILOXANE
定义
Cyclohexasiloxane is the cyclic dimethyl polysiloxane that conforms to the formula, where n equals 6, and the other components of cyclomethicone (where n equals 4, 5, or 7) are present at levels of less than 1%.
이 원료는 사이클릭다이메틸폴리실록세인이며 n이 6인 다음의 구조를 갖는다. n이 4, 5, 7인 사이클로메티콘의 다른 성분들은 1%미만이다.
식약처 원료 정의: 이 원료는 사이클릭다이메틸폴리실록세인이며 n이 6인 다음의 구조를 갖는다. n이 4, 5, 7인 사이클로메티콘의 다른 성분들은 1%미만이다.
官方标示名称和定义
JCIA 표시명 シクロヘキサシロキサン: 本品は、環状ポリシロキサンであり、次の化学式で表される。
别名和识别信息
- cas
- 540-97-6
- ec
- 208-762-8
- dtxsid
- DTXSID6027183
- dtxcid
- DTXCID507183
- IUPAC
- Dodecamethylcyclohexasiloxane
- 분자식
- C12H36O6Si6
- 분자량
- 444.924 g/mol
化妆品中的作用
含有此成分的产品
확인된 3개 중 3개 · 무작위 순서
安全与法规参考
Restriction Restricted under COMMISSION REGULATION (EU) 2024/1328. 1. Shall not be placed on the market (a) as a substance on its own; (b) as a constituent of other substances; or (c) in mixtures; in a concentration equal to or greater than 0,1 % by weight of the respective substance after 6 June 2026. [...] 3. By way of derogation: (a) for D4 and D5 in wash-off cosmetic products, paragraph 1, point (c), shall apply after 31 January 2020. For the purposes of this point, “wash-off cosmetic products” means cosmetic products as defined in Article 2(1), point (a), of Regulation (EC) No 1223/2009 of the European Parliament and of the Council (*1) that, under normal conditions of use, are washed off with water after application; (b) for all cosmetic products other than the ones mentioned in paragraph 3(a), paragraph 1 shall apply after 6 June 2027.
Reviewed by CIR: Safety assessment of Cyclomethicone, Cyclotetrasiloxane, Cyclopentasiloxane, Cyclohexasiloxane and Cycloheptasiloxane
已关联的官方原始数据
相关文献
- Multi-Target Anti-Aging Mechanisms of Multani Mitti (Fuller’s Earth): Integrating Enzyme Inhibition and Molecular Docking for Cosmeceuticals · 2025
- Phytochemical and GC-MS Analysis of Dendrophthoe falcata (L.f.) Ettingsh Stem · 2019
- Risk assessment of cyclohexasiloxane D6 in cosmetic products · 2024
- Evaluation of anti-inflammatory, analgesic and TNF-α inhibition (upon RAW 264.7 cell line) followed by selection of extract (leaf and stem) with respect to potency to introduce anti-oral-ulcer model obtained from Olax psittacorum (Lam.) Vahl in addition to GC-MS illustration. · 2020
- Safety Assessment of Cyclomethicone, Cyclotetrasiloxane, Cyclopentasiloxane, Cyclohexasiloxane, and Cycloheptasiloxane · 2011